Literature DB >> 2342239

Diagnosis of cardiac allograft rejection by the detection of circulating plasma cardiac myosin light chains.

M Kawauchi1, Y Yazaki, T Oka, H Okabe, M Mathison, J Nakajima, O Morizuki, G Kawaguchi, K Koseni, M Takeda.   

Abstract

Twenty adult male Japanese monkeys of the species Macaca fuscata were randomly paired and subjected to heterotopic cardiac transplantation performed by the Ono-Lyndsey method. Without immunosuppression, graft survival ranged between 8 and 27 days, with a mean survival of 14 days. Plasma cardiac myosin light chains were measured by radioimmunoassay, which showed transient increases in myosin levels just following transplantation. Three hearts showed high values at this period and stopped beating when the myosin levels decreased (type 1). The other 7 hearts showed low myosin values after transient increases and 5 of them were rejected with a preceding reincrease in the myosin levels (type 2). Pathological study revealed myocardial necrosis, perivascular cuffing of mononuclear cells and/or neutrophils and/or plasma cells in the type 1 hearts. Measurement of the plasma myosin light chain level was therefore revealed to be of great value in the monitoring of cardiac allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342239     DOI: 10.1007/bf02470771

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  Cardiac transplantation in man. VII. Cardiac allograft pathology.

Authors:  C P Bieber; E B Stinson; N E Shumway; R Payne; J Kosek
Journal:  Circulation       Date:  1970-05       Impact factor: 29.690

2.  Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic resonance imaging, two-dimensional echocardiography, and endocardial biopsy.

Authors:  T S Hall; W A Baumgartner; A M Borkon; N D LaFrance; T A Traill; S Norris; G M Hutchins; J Brawn; B A Reitz
Journal:  J Heart Transplant       Date:  1986 Nov-Dec

3.  Is In-111 antimyosin antibody a useful diagnostic marker for evaluation of early cardiac allograft rejection?

Authors:  K Ueda; K Takeda; N D LaFrance; K Solez; W A Baumgartner; B A Reitz; A Herskowitz
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

4.  Myosin content and myosin isoenzyme distribution in the heterotopic rat heart allograft.

Authors:  I Klein; C Hong; T R Zerbe
Journal:  J Mol Cell Cardiol       Date:  1987-09       Impact factor: 5.000

5.  Cellular basis for accumulation of In-111-labeled leukocytes and platelets in rejecting cardiac allografts: concise communication.

Authors:  T S Wang; S Oluwole; R A Fawwaz; M Wolff; N Kuromoto; K Satake; M A Hardy; P O Alderson
Journal:  J Nucl Med       Date:  1982-11       Impact factor: 10.057

6.  Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model.

Authors:  K G Lurie; M E Billingham; S W Jamieson; D C Harrison; B A Reitz
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

7.  Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging.

Authors:  W Frist; T Yasuda; G Segall; B A Khaw; H W Strauss; H Gold; E Stinson; P Oyer; J Baldwin; M Billingham
Journal:  Circulation       Date:  1987-11       Impact factor: 29.690

8.  Evaluation of methods for estimating infarct size by myosin LC2: comparison with cardiac enzymes.

Authors:  R Nagai; C C Chiu; K Yamaoki; Y Ohuchi; S Ueda; K Imataka; Y Yazaki
Journal:  Am J Physiol       Date:  1983-09

9.  Quantifying cell death in the myocardium: myosin specific antibody in the evaluation of membrane defects.

Authors:  E Haber
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

10.  Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis.

Authors:  D V Cramer; S Q Qian; J Harnaha; F A Chapman; L W Estes; T E Starzl; L Makowka
Journal:  Transplantation       Date:  1989-03       Impact factor: 4.939

  10 in total
  1 in total

1.  Expression of cell division cycle 2 kinase transcription in chronically rejected cardiac allografts of nonhuman primates.

Authors:  A Schoenbeck; M Isobe; J Suzuki; M Kato; N Kitazawa; J Amano; M Endoh; M Kawauchi; S Takamoto; M Sekiguchi
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.